Figure 1
From: A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
Patient 16, Male, GA 27 weeks, BW 970 g, treated at 44 weeks’ PMA. He had stage 3+ in zone II ROP diseases, received only one injection of conbercept after the first fundus examination, and the situation of plus disease and ridge was consecutively observed for 55 weeks. (A,B) Shows the right eye with plus and ridge before conbercept injection. (C,D) Shows the same eye regression of plus disease, ridge and the disappearance or decrease of retinal vessel tortuosity, and the growth of the normal retinal vessels toward the peripheral retina 55 weeks after conbercept injection.
